Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid-sparing effect

Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid-sparing effect. Chen, D. M.; Odueyungbo, A.; Csinady, E.; Gearhart, L.; Lehane, P.; Cheu, M.; Maho-Vaillant, M.; Prost-Squarcioni, C.; Hebert, V.; Houivet, E.; Calbo, S.; Caillot, F.; Golinski, M. L.; Labeille, B.; Picard-Dahan, C.; Paul, C.; Richard, M. A.; Bouaziz, J. D.; Duvert-Lehembre, S.; Bernard, P.; Caux, F.; Alexandre, M.; Ingen-Housz-Oro, S.; Vabres, P.; Delaporte, E.; Quereux, G.; Dupuy, A.; Debarbieux, S.; Avenel-Audran, M.; D'Incan, M.; Bedane, C.; Bénéton, N.; Jullien, D.; Dupin, N.; Misery, L.; Machet, L.; Beylot-Barry, M.; Dereure, O.; Sassolas, B.; Benichou, J.; Musette, P.; Joly, P.; French Study Group on Autoimmune Bullous Diseases. The British Journal of Dermatology. 2019; : . doi:10.1111/bjd.18482
Article